Lifeward (LFWD) Cash from Financing Activities (2015 - 2026)
Lifeward (LFWD) posted Cash from Financing Activities of $6.4 million for Q1 2026, up 69.98% sequentially from $3.8 million in Q4 2025, and up 43.64% YoY from $4.5 million in Q1 2025.
Lifeward (LFWD) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Lifeward has reported Cash from Financing Activities for 11 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 43.64% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (up 216.57% YoY) and the FY2025 annual result came in at $12.2 million, changed N/A from the prior year.
- Cash from Financing Activities climbed to $6.4 million in Q1 2026 per LFWD's latest filing, from $3.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $6.4 million in Q1 2026 and troughed at -$2.3 million in Q4 2022.
- A 4-year average of $1.5 million and a median of $320000.0 in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 682.77% in 2022, then soared 96.72% in 2023.
- Over 4 years, Cash from Financing Activities stood at -$2.3 million in 2022, then soared by 99.74% to -$6000.0 in 2023, then soared by 63066.67% to $3.8 million in 2025, then surged by 69.98% to $6.4 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $6.4 million, $3.8 million, and $646000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Lifeward | 20.11 Mn | 10.66 Mn | 2.71 Mn | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 646,000.00 |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Dec 31, 2022 | -2.32 Mn |
| Dec 31, 2022 | -2.32 Mn |
| Sep 30, 2022 | -183,000.00 |
| Sep 30, 2022 | -183,000.00 |